1 research outputs found
Identifying and Assessing Putative Allosteric Sites and Modulators for CXCR4 Predicted through Network Modeling and Site Identification by Ligand Competitive Saturation
The chemokine receptor CXCR4 is a critical target for
the treatment
of several cancer types and HIV-1 infections. While orthosteric and
allosteric modulators have been developed targeting its extracellular
or transmembrane regions, the intramembrane region of CXCR4 may also
include allosteric binding sites suitable for the development of allosteric
drugs. To investigate this, we apply the Gaussian Network Model (GNM)
to the monomeric and dimeric forms of CXCR4 to identify residues essential
for its local and global motions located in the hinge regions of the
protein. Residue interaction network (RIN) analysis suggests hub residues
that participate in allosteric communication throughout the receptor.
Mutual residues from the network models reside in regions with a high
capacity to alter receptor dynamics upon ligand binding. We then investigate
the druggability of these potential allosteric regions using the site
identification by ligand competitive saturation (SILCS) approach,
revealing two putative allosteric sites on the monomer and three on
the homodimer. Two screening campaigns with Glide and SILCS-Monte
Carlo docking using FDA-approved drugs suggest 20 putative hit compounds
including antifungal drugs, anticancer agents, HIV protease inhibitors,
and antimalarial drugs. In vitro assays considering
mAB 12G5 and CXCL12 demonstrate both positive and negative allosteric
activities of these compounds, supporting our computational approach.
However, in vivo functional assays based on the recruitment
of β-arrestin to CXCR4 do not show significant agonism and antagonism
at a single compound concentration. The present computational pipeline
brings a new perspective to computer-aided drug design by combining
conformational dynamics based on network analysis and cosolvent analysis
based on the SILCS technology to identify putative allosteric binding
sites using CXCR4 as a showcase